Index
S&P 500
Market Cap
54.62B
Enterprise Value
59.87B
Income
1.71B
Sales
254.25B
Book/sh
-12.37
Cash/sh
20.88
Employees
63900
IPO
Aug 04, 1983
P/E
32.45
Forward P/E
16.67
PEG
1.44
P/S
0.21
P/B
-
P/C
11.25
P/FCF
12.07
EV/EBITDA
14.13
EV/Sales
0.24
Quick Ratio
0.49
Current Ratio
0.88
Debt/Eq
-
LT Debt/Eq
-
Option/Short
Yes / Yes
EPS (ttm)
7.24
EPS next Y
14.09
EPS next Q
2.94
EPS this Y
11.39%
EPS next Y
12.34%
EPS next 5Y
11.59%
EPS past 3/5Y
79.07% 28.33%
Sales past 3/5Y
7.44% 9.37%
EPS Y/Y TTM
12.28%
Sales Y/Y TTM
14.23%
EPS Q/Q
70.07%
Sales Q/Q
5.84%
Insider Own
0.43%
Insider Trans
-0.27%
Inst Own
90.34%
Inst Trans
-2.41%
ROA
3.10%
ROE
-
ROIC
34.40%
Gross Margin
3.70%
Oper. Margin
1.29%
Profit Margin
0.67%
SMA20
0.62%
SMA50
1.62%
SMA200
9.98%
Trades
Shs Outstand
233.00M
Shs Float
231.58M
52W High
258.30 -9.08%
52W Low
145.87 61.00%
Volatility
2.40% 2.69%
ATR (14)
6.29
RSI (14)
53.43
Beta
0.52
Rel Volume
0.00
Avg Volume
2.24M
Volume
0
Perf Week
0.29%
Perf Month
3.42%
Perf Quarter
17.21%
Perf Half Y
4.38%
Perf YTD
14.28%
Perf Year
57.60%
Perf 3Y
173.56%
Perf 5Y
357.62%
Perf 10Y
187.38%
Prev Close
234.85
Price
234.85
Change %
0.00%
Date
Action
Analyst
Rating Change
Price Target Change
Aug-19-26 Initiated
RBC Capital Mkts
Outperform
$276
Apr-28-26 Initiated
William Blair
Outperform
Jan-09-26 Upgrade
Citigroup
Neutral → Buy
Dec-09-25 Initiated
Barclays
Overweight
$243
Jun-03-25 Upgrade
Wells Fargo
Equal Weight → Overweight
$179
Feb-05-25 Upgrade
Jefferies
Hold → Buy
$140 → $150
Jan-08-25 Upgrade
TD Cowen
Hold → Buy
$130 → $144
Jan-07-25 Upgrade
Evercore ISI
In-line → Outperform
$140
Jan-06-25 Upgrade
BofA Securities
Neutral → Buy
$132 → $145
Dec-13-24 Upgrade
Wells Fargo
Underweight → Equal Weight
$101 → $127
Dec-04-24 Resumed
Mizuho
Outperform
$139
Feb-26-24 Initiated
Leerink Partners
Outperform
$125
Feb-09-24 Upgrade
Argus
Hold → Buy
Jan-03-24 Initiated
Barclays
Overweight
$117
Dec-14-23 Initiated
Wells Fargo
Underweight
$96
Jul-10-23 Downgrade
Evercore ISI
Outperform → In-line
$100
Mar-31-23 Initiated
Citigroup
Neutral
$77
Feb-03-23 Upgrade
Robert W. Baird
Neutral → Outperform
$87 → $94
Nov-04-22 Upgrade
BofA Securities
Underperform → Neutral
$64 → $80
Aug-22-22 Resumed
Morgan Stanley
Overweight
$70 → $76
Show Previous Ratings
Aug-19-26 09:38AM
Aug-18-26 07:13AM
Aug-13-26 06:10PM
Aug-11-26 05:03PM
01:25PM
10:13AM
Loading…
10:13AM
10:07AM
(Investor's Business Daily)
09:02AM
(Investor's Business Daily)
08:54AM
08:00AM
07:38AM
07:25AM
(The Wall Street Journal)
07:03AM
06:45AM
06:40AM
05:10AM
Loading…
05:10AM
04:06AM
Jul-27-26 09:54AM
Jul-21-26 12:15PM
04:46AM
Jul-20-26 04:45PM
Jul-09-26 09:24AM
06:45AM
Jul-08-26 02:24PM
May-05-26 04:40PM
Apr-30-26 04:55PM
08:07AM
07:41AM
(The Wall Street Journal)
06:56AM
06:45AM
12:30AM
Loading…
12:30AM
Apr-28-26 11:45AM
10:19AM
Apr-20-26 12:12PM
Apr-14-26 07:00AM
Apr-07-26 08:20PM
Apr-01-26 07:00AM
Mar-24-26 06:45AM
Mar-23-26 06:45AM
Mar-13-26 04:41PM
(Investor's Business Daily)
09:55AM
Mar-10-26 01:11PM
10:55AM
Mar-09-26 11:53AM
09:40AM
Mar-06-26 07:12PM
11:49AM
11:45AM
11:44AM
Mar-05-26 12:46PM
10:56AM
09:30AM
07:43AM
Mar-04-26 11:35AM
08:30AM
Mar-03-26 10:38PM
07:02PM
09:40AM
09:15AM
Mar-02-26 12:59PM
09:40AM
09:36AM
07:41AM
07:41AM
Feb-28-26 01:28PM
Feb-27-26 12:45PM
12:38PM
12:37PM
07:42AM
Feb-26-26 08:04PM
07:12PM
11:46AM
11:22AM
Feb-25-26 01:55PM
01:55PM
12:51PM
12:49PM
07:50AM
07:26AM
Feb-24-26 12:40PM
12:15PM
08:46AM
07:45AM
07:00AM
Feb-23-26 03:35PM
12:42PM
10:11AM
09:32AM
Feb-20-26 06:11PM
12:22PM
11:48AM
09:11AM
04:13AM
Feb-19-26 04:44PM
12:08PM
09:40AM
08:33AM
08:16AM
08:09AM
Feb-18-26 08:55AM
Cardinal Health, Inc. is a healthcare services and products company, which engages in the provision of customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, and physician offices. It also provides medical products and pharmaceuticals and cost-effective solutions that enhance supply chain efficiency. The firm operates through the Pharmaceutical and Specialty Solutions Segment and Global Medical Products and Distribution Segment. The Pharmaceutical and Specialty Solutions Segment distributes branded and generic pharmaceutical, specialty pharmaceutical, and over-the-counter healthcare and consumer products in the United States. The Global Medical Products and Distribution Segment manufactures, sources, and distributes Cardinal Health brand medical, surgical, and laboratory products, which are sold in the United States, Canada, Europe, Asia, and other markets. The company was founded by Robert D. Walter in 1979 and is headquartered in Dublin, OH.
CEO & Director Mr. Jason M. Hollar
Chief Executive Officer of Pharmaceutical & Specialty Solutions Segment Ms. Deborah L. Weitzman
Senior VP & Chief Accounting Officer Ms. Mary C. Scherer
Chief Human Resources Officer Ms. Valerie Christine Pitteroff
President of Biopharma Solutions & Strategic Sourcing Mr. Craig Cowman
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Mary Scherer Officer Aug 19 '26 Proposed Sale 237.39 2,302 546,462 Aug 19 04:27 PM Aaron Alt Officer Aug 18 '26 Proposed Sale 236.34 42,000 9,926,183 Aug 18 04:46 PM Michelle Greene Officer Aug 18 '26 Proposed Sale 235.72 11,650 2,746,148 Aug 18 04:46 PM Deborah Weitzman Officer Aug 18 '26 Proposed Sale 235.45 7,354 1,731,534 Aug 18 04:45 PM Jessica Mayer Officer Aug 18 '26 Proposed Sale 236.19 29,436 6,952,441 Aug 18 04:45 PM Stephen Mason Officer Aug 18 '26 Proposed Sale 236.40 35,000 8,274,153 Aug 18 04:44 PM Jason Hollar Officer Aug 18 '26 Proposed Sale 235.74 124,529 29,356,358 Aug 18 04:44 PM Gregory Kenny Former Director Jun 08 '26 Proposed Sale 203.84 43,542 8,875,761 Jun 08 04:01 PM Greene Michelle D. Chief Information Officer Feb 27 '26 Sale 228.47 2,746 627,387 12,230 Mar 03 04:11 PM Michelle Greene officer Feb 27 '26 Proposed Sale 228.47 2,746 627,387 Feb 27 04:36 PM Alt Aaron E Chief Financial Officer Feb 18 '26 Sale 225.50 2,328 524,964 26,408 Feb 18 04:25 PM Aaron Alt Officer Feb 18 '26 Proposed Sale 225.50 2,328 524,964 Feb 18 04:16 PM Hall Patricia Hemingway Director Feb 06 '26 Sale 229.72 4,000 918,880 28,264 Feb 10 04:13 PM Patricia Hemingway Hall Director Feb 06 '26 Proposed Sale 229.69 4,000 918,760 Feb 06 04:06 PM